Seattle-King County Health Department

Seattle, Washington 98104

1 studies enrolling now · 15 studies all time

What they study most

HIV Infections, Latent Tuberculosis, Pulmonary Tuberculosis, Tuberculosis, Tuberculosis, Pulmonary

Studies at this site

• Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI — Recruiting now
• TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment — Completed
• TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection — Completed
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection — Completed
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz — Completed
• TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance — Completed
• TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment — Completed
• TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment — Completed
• TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment — Completed
• TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis — Completed
• TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB — Completed
• TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine — Completed
• TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis — Completed
• TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB — Completed
• TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen — Completed